Passive immunity to bovine rotavirus infection associated with transfer of serum antibody into the intestinal lumen.
The effect of circulating passive antibody on immunity to bovine rotavirus infections in neonatal calves was investigated. In the first experiment, rotavirus antibody titers in the small intestinal lumina of 5- and 10-day-old calves with a wide range of serum rotavirus antibody titers were determined. Neutralizing antibody was present in the small intestinal lumina in titers that correlated with the calves' serum titers (r = +0.84, P less than 0.01). Immunoglobulin G1 was the predominant isotype of intestinal luminal rotavirus antibody. Calves not fed colostrum during the absorptive period lacked rotavirus antibody in circulation and in the intestinal lumen at 7 days of age, even when they were fed large volumes of colostrum with a high rotavirus antibody titer at 48 h after birth. Therefore, rotavirus antibody is not retained in the intestinal lumen for 5 days following a colostrum meal, and the luminal antibody in the 5- and 10-day-old seropositive calves were probably derived from circulating antibody. In a second experiment, calves were passively immunized by subcutaneous injection of colostral whey with a high immunoglobulin G1 rotavirus antibody titer and challenged with virulent bovine rotavirus 48 h later. The passively immunized calves were protected from rotavirus infection and diarrhea compared with calves with comparable serum immunoglobulin concentrations but with lower serum rotavirus with lower serum rotavirus antibody titers. The results of these experiments indicate that circulating immunoglobulin G1 antibody appears in the gastrointestinal tract of neonatal calves and that circulating rotavirus antibody can prevent infection and diarrhea after rotavirus challenge.
Besser
T E
TE
Department of Veterinary Clinical Medicine and Surgery, College of Veterinary Medicine, Washington State University, Pullman 99164-6610.
Gay
C C
CC
McGuire
T C
TC
Evermann
J F
JF
D000818:Animals; D000831:Animals, Newborn; D000914:Antibodies, Viral / Q000008:administration & dosage / Q000378:metabolism*; D002417:Cattle / Q000276:immunology* / Q000378:metabolism; D003126:Colostrum / Q000378:metabolism; D003967:Diarrhea / Q000517:prevention & control / Q000662:veterinary; D004064:Digestive System / Q000276:immunology* / Q000378:metabolism; D005766:Gastrointestinal Contents; D007116:Immunization, Passive; D007074:Immunoglobulin G / Q000008:administration & dosage / Q000378:metabolism*; D007273:Injections, Intramuscular; D007279:Injections, Subcutaneous; D008297:Male; D012401:Rotavirus / Q000276:immunology*; D012400:Rotavirus Infections / Q000517:prevention & control / Q000662:veterinary
D000914:Antibodies, Viral; D007074:Immunoglobulin G